K841243

Substantially Equivalent

ENZYGNOST ROTAVIRUS AG

Applicant: Behring Diagnostics, Inc.
Product code: LIQ
Advisory panel: Microbiology
Date received: 1984-03-23
Decision date: 1984-10-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: La Jolla, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.